{
  "ticker": "MEM",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02960169",
  "id": "02960169",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250619",
  "time": "1706",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250619/pdf/06kxfqpsjphsrb.pdf",
  "summary": "- **Appointment of Non-Executive Director**: Marjan Mikel appointed, bringing experience in Medtech/diagnostics commercialization, capital markets, and strategic partnerships.  \n- **Relevance**: Prior involvement with Memphasys (2018\u20132020) and leadership at ASX-listed Vitasora Health may support commercialization of Felix\u2122 and RoXsta\u2122 platforms.  \n\nNo material trading or capital markets impact identified.",
  "usage": {
    "prompt_tokens": 1174,
    "completion_tokens": 86,
    "total_tokens": 1260,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-19T07:34:27.114990"
}